Question 1

What is the catalog number for CGB2 (Choriogonadotropin Subunit beta Variant 2) (MaxLight 405) discontinued?

Accepted Answer

The catalog number for CGB2 (Choriogonadotropin Subunit beta Variant 2) (MaxLight 405) discontinued is 124910-ML405.

Question 2

What sizes are available for CGB2 (Choriogonadotropin Subunit beta Variant 2) (MaxLight 405) discontinued?

Accepted Answer

CGB2 (Choriogonadotropin Subunit beta Variant 2) (MaxLight 405) discontinued is available in the following size(s): 100 µL.

Question 3

Is CGB2 (Choriogonadotropin Subunit beta Variant 2) (MaxLight 405) discontinued in stock?

Accepted Answer

CGB2 (Choriogonadotropin Subunit beta Variant 2) (MaxLight 405) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

CGB2 (Choriogonadotropin Subunit beta Variant 2) (MaxLight 405) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Bcl-x (BX006), CF647 conjugate, 0.1mg/mL

Recombinant Calreticulin Antibody

Recombinant Calreticulin Antibody

Recombinant Calreticulin Antibody

Human Ribonuclease 7 (RNASE7) activation kit by CRISPRa

CALY Polyclonal Antibody